Noa Alon

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Peripheral blood DNA methylation predicts the early onset of primary tumor in TP53 mutation carriers.

Peripheral blood DNA methylation predicts the early onset of primary tumor in TP53 mutation carriers.

Journal: Nature communications
Published: January 18, 2025

TP53 variant clusters stratify phenotypic diversity in germline carriers and reveal an osteosarcoma-prone subgroup.

TP53 variant clusters stratify phenotypic diversity in germline carriers and reveal an osteosarcoma-prone subgroup.

Journal: Nature communications
Published: February 12, 2024

Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome.

Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome.

Journal: Cancer research communications
Published: October 07, 2022

Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome.

Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome.

Journal: Nature communications
Published: December 15, 2019

BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.

BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 11, 2015

Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors.

Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors.

Journal: Acta neuropathologica
Published: July 17, 2014

Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.

Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.

Journal: The Lancet. Oncology
Published: April 20, 2013

Monoallelic expression determines oncogenic progression and outcome in benign and malignant brain tumors.

Monoallelic expression determines oncogenic progression and outcome in benign and malignant brain tumors.

Journal: Cancer research
Published: December 07, 2011
Showing 1-8 of 8

Last Updated: 09/26/2026